Bibliografia
Taylor M, Bhagwandas K. N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders Br J Dermatol. 2014 Nov;171(5):1253-5. doi: 10.1111/bjd.13080. Epub 2014 Oct 22. PMID: 24773206. Fischer TW, Slominski A, Zmijewski MA, Reiter RJ, Paus R. Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol. 2008 Sep;17(9):713-30. doi: 10.1111/j.1600- 0625.2008.00767.x.Epub 2008 Jul 17. PMID: 18643846. Ibrahim H, Perl A, Smith D, Lewis T, Kon Z, Goldenberg R, Yarta K, Staniloae C, Williams M. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N acetylcysteine. Clin Immunol. 2020 Oct;219:108544. doi:10.1016/j.clim.2020.108544. Epub 2020 Jul 22. PMID: 32707089; PMCID: PMC7374140. Zhou N, Yang X, Huang A, Chen Z. The potential mechanism of N- acetylcysteine in treating COVID-19. Curr Pharm Biotechnol. 2020 Dec 28. doi: 10.2174/1389201021999201228212043. Epub ahead of print. PMID: 33371832. Shi Z, Puyo CA. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Ther Clin Risk Manag. 2020 Nov 2;16:1047-1055. doi: 10.2147/TCRM.S273700. PMID: 33177829; PMCID: PMC7649937. Lipner SR. Rethinking biotin therapy for hair, nail, and skin disorders. J Am Acad Dermatol. 2018 Jun;78(6):1236-1238. doi: 10.1016/j.jaad.2018.02.018. Epub 2018 Feb 10. PMID: 29438761. Piraccini BM, Berardesca E, Fabbrocini G, Micali G, Tosti A. Biotin: overview of the treatment of diseases of cutaneous appendages and of hyperseborrhea. G Ital Dermatol Venereol. 2019 Oct;154(5):557-566. doi: 10.23736/S0392-0488.19.06434-4. PMID: 31638351. Analysis of serum zinc and copper concentrations in hair loss. Kil MS, Kim CW, Kim SS AnnDermatol. 2013 Nov; 25(4):405-9. Nutrition and hair: deficiencies and supplements. Finner AM Dermatol Clin. 2013 Jan; 31(1):167-72. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV: international version with icd-10 codes. American Psychiatric Publishing, Inc. pub. American Psychiatric Association, Ed. it. Massimo Biondi (a cura di), DSM-5. Manuale diagnostico e statistico dei disturbi mentali, Milano, Raffaello Cortina Editore, 2014. ISBN 978 -88-6030-661-6 American PsychiatricAssociation, Ed. it., Criteri diagnostici Mini DSM-5, Milano, Raffaello Cortina Editore, 2014. ISBN 978- 88-6030-662-3 Abraham M. Nussbaum, Ed. It., L’esame diagnostico con il DSM-5, Milano, Raffaello Cortina Editore, 2014. ISBN 978-88-6030-663-0 Browne, T.R., Holmes, G.L. (2001) Epilepsy. N. Engl. J. Med. 344, 1145- 1151 Francesca Santoro: “quando gli psicofarmaci bisogna proprio prenderli” 2007, Stella Arti Grafiche Trieste Hyman, S.E., Kandel, E. (2008) Biology of psychiatric disorders. In: Fauci, A.S., Braunwald, E., Kasper, D.L., Hauser, S.L., Longo, D.L., Jameson, J.L., Loscalzo, J. (eds.) Harrison’s principles of internal medicine. XVII ed. Mc Graw Hill, New York Jackson, J. H. (1863) Unilateral epileptiform seizures, attended by temporary defect of sight. Medical Times and Gazette, London 1, 588-589 Kandel, E.R., Schwartz, J.H., Jessel, T.M. (2000) Principles of neural science. IV ed. MacGraw Hill, New York Liotta, L.A., Belluco, C., Petricoin, E.F. III (2008) Genomics and proteomics. In: DeVita, V.T. Lawrence, T.S., Rosenberg, S.A. (eds.) Martin, J.B. (1999) Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340, 1970- 1980 Mignot, E., Shahrad Taheri, S., Nishino, S. (2002) Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat. Neurosci. 5, 1071-1075 Reus, V. (2008) Mental disorders. In: Fauci, A.S., Braunwald, E., Kasper, D.L., Hauser, S.L., Longo, D.L., Jameson, J.L., Loscalzo, J., (eds) Harrison’s principles of internal medicine. XVII ed. Mc Graw Hill, New York Robert Spitzer et al, DSM-IV-TR casiclinici. Applicazioni cliniche del manuale diagnostico e statistico dei disturbi mentali, Milano, Elsevier, 2003. ISBN 88-214-2676-9; ISBN 978-88-214-2676- 6. Anteprima limitata disponibile su books.google.it Vittorino Andreoli, Giovan Battista Cassano, Romolo Rossi (a cura di), DSM-IV. Manuale diagnostico e statistico dei disturbi mentali, Milano, Elsevier, 2ª ed: 2002. ISBN 88-214-2588-6; ISBN 978-88-214-2588-2. Anteprima limitata su books.google.it Vittorino Andreoli, Giovan Battista Cassano, Romolo Rossi, Mini DSM-IV-TR. Criteri diagnostici, Milano, Elsevier, 2002. ISBN 88-214-2614-9; ISBN 978-88-214-2614-8. Anteprima limitata su books.google.it John W. Barnhill (a cura di), Casi clinici DSM-5, Milano, Raffaello Cortina Editore, 2014. ISBN 978-88-6030-664-7 Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R – Indications for a ‘brain-hair follicle axis (BHA)’: inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P – The FASEB Journal. 2001;15:2536-2538. Aron B.R., Binet O., Dompmartin P.D.: “Diagnostic des alopécies diffuses. Une approche objective: le trichogramma” Rev. Médicine1977; 18: 1263. Barman J.M., Astore I., Pecoraro V.: “The normal trichogram of the adult” J. Invest. Derm 1965; 42: 421. Bekhor P.S.: “Common hair disorders” Australian Family Physician 1986; vol 15, 7: 868. Bertamino R.: “Alopecie” in F. Serri et al (Eds) “Trattato di Dermatologia” Piccin, Padova 1987, cap 75. Marliani A.: “I grandi effluvi” in Marliani A. et al (Eds): “I Capelli” Etruria Medica, Firenze, 1989: 70-72. Kligman A.M.: “Pathologic dynamics of human hair loss, I. Telogen effluvium” Arch Dermatol 1961; 83: 175 -198. Pochi P.E., Strauss J.S.: “Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment” Clin Exp Dermatol 1976; 112: 1108. Rassman W.R.: “The measurement of hair density in the diagnosis and treatment of hair loss” J DermatolSurgOncol 1994; 20/11: 773. Rebora A., Guarrera M, Semino M.T.: “Trichodynia” Dermatology 1996;192: 292-293